Global Dermal Fillers Market Size study & Forecast, by Material (Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-lactic Acid, PMMA (Poly (Methyl Methacrylate)), Fat Fillers, Others) by Product (Biodegradable, Non-Biodegradable), by Application (Scar Trea

Global Dermal Fillers Market Size study & Forecast, by Material (Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-lactic Acid, PMMA (Poly (Methyl Methacrylate)), Fat Fillers, Others) by Product (Biodegradable, Non-Biodegradable), by Application (Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration of Volume/Fullness, Others), by End-User (Specialty & Dermatology Clinics, Hospitals & Clinics, Others), and Regional Analysis, 2022-2029

Global Dermal Fillers Market is valued at approximately USD 5.05 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2022-2029. Dermal fillers are a minimally invasive aesthetic procedure used to temporarily reduce fine lines, soften creases on the face, and smooth out wrinkles. It is an injectable gel-like substance that is used to generate an attractive effect by giving the skin on the face greater fullness and volume. Dermal fillers contain a variety of materials, including microspheres of polymethyl methacrylate, poly-L-lactic acid, and hyaluronic acid (HA) (PMMA). Dermal fillers can be used for a variety of purposes, such as scar removal, lip enhancement, wrinkle reduction, and the restoration of lost volume. The increasing adoption of injectable fillers among the male population, rising awareness regarding facial aesthetics in developed nations, and the surging number of elderly populations are the primary factors that are bolstering the market demand around the world.

In addition, the increase in demand for minimally invasive cosmetic procedures and dermal filler procedures are the key factors that are attributing to the market growth at a substantial rate globally. According to the American Society of Plastic Surgeons study. In the United States, there were over 13.2 million cosmetic procedures performed in 2020, of which 3.4 million used soft tissue fillers. Such compelling data further demonstrates the sharp rise in demand for cosmetic operations. Also, according to the International Society of Aesthetic Plastic Surgery (ISAPS) it was assessed that around 4,315,859 hyaluronic acid filler treatments were carried out globally in 2019 in comparison to 2018, this marked a rise of 15.7%. Thus, the rise in the volume of aesthetic operations is anticipated to further support market expansion throughout the projected period. Furthermore, the increasing R&D initiatives for the development of new fillers, as well as rising technological advancement in medical aesthetic products are creating various lucrative opportunities for market growth over the anticipated years. However, relative side effects with the dermal filler procedure and high costs associated with products are hampering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Dermal Fillers Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the increasing number of hyaluronic acid procedures, along with the rising regulatory approvals and new product launches. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increasing consciousness of individuals regarding their physical appearance, escalating aging population, as well as the increasing disposable income in the regional market.

Major market players included in this report are:
Revance Therapeutics, Inc. (U.S.)
Merz Pharma (Germany)
Galderma (Switzerland)
Sinclair Pharma (U.K.)
BIOPLUS CO., LTD. (South Korea)
Bioxis pharmaceuticals (France)
SCULPT Luxury Dermal Fillers LTD (Czech Republic)
DR. Korman Laboratories Ltd. (Israel)
Prollenium Medical Technologies (Canada)
Suneva Medical (U.S.)

Recent Developments in the Market:
 In February 2021, CollPlant and Allergan Aesthetica jointly announced a development and global commercial partnership to create and market dermal and soft tissue fillers using CollPlant's plant-derived recombinant human collagen (rhCollagen) and Allergan's patented technology.


Global Dermal Fillers Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Material, Product, Application, End-User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Material:
Hyaluronic Acid
Calcium Hydroxylapatite
Poly-L-lactic Acid
PMMA (Poly (Methyl Methacrylate))
Fat Fillers
Others
By Product:
Biodegradable
Non-Biodegradable
By Application:
Scar Treatment
Wrinkle Correction Treatment
Lip Enhancement
Restoration of Volume/Fullness
Others
By End-User:
Specialty & Dermatology Clinics
Hospitals & Clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned
Revance Therapeutics, Inc. (U.S.)
Merz Pharma (Germany)
Galderma (Switzerland)
Sinclair Pharma (U.K.)
BIOPLUS CO., LTD. (South Korea)
Bioxis pharmaceuticals (France)
SCULPT Luxury Dermal Fillers LTD (Czech Republic)
DR. Korman Laboratories Ltd. (Israel)
Prollenium Medical Technologies (Canada)
Suneva Medical (U.S.)

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.